Similar articles

• Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation.

  Elmaagacli AH, Koldehoff M, Landt O, Beelen DW. Elmaagacli AH, et al. Bone Marrow Transplant. 2008 May;41(9):821-6. doi: 10.1038/sj.bmt.1705980. Epub 2008 Jan 21. Bone Marrow Transplant. 2008. PMID: 18209723
• Interleukin-10 and graft-versus-host disease.

  Kida Y. Kida Y. N Engl J Med. 2004 Mar 25;350(13):1361-2; author reply 1361-2. doi: 10.1056/NEJMc033110. N Engl J Med. 2004. PMID: 15044650 No abstract available.
• Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.

  Kim I, Keam B, Lee KH, Kim JH, Oh SY, Ra EK, Yoon SS, Park SS, Kim CS, Park S, Hong YC, Kim BK. Kim I, et al. Clin Transplant. 2007 Mar-Apr;21(2):207-13. doi: 10.1111/j.1399-0012.2006.00624.x. Clin Transplant. 2007. PMID: 17425746
• Immunity and transplantation.

  Navarrete CV. Navarrete CV. Vox Sang. 2004 Jul;87 Suppl1:39-42. doi: 10.1111/j.1741-6892.2004.00427.x. Vox Sang. 2004. PMID: 15200602 Review. No abstract available.
• Immunogenomics and proteomics in hematopoietic stem cell transplantation: predicting post-hematopoietic stem cell transplant complications.

  Weissinger EM, Dickinson AM. Weissinger EM, et al. Cancer Treat Res. 2009;144:95-129. doi: 10.1007/978-0-387-78580-6_5. Cancer Treat Res. 2009. PMID: 19779872 Review. No abstract available.